Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER - Aladin, F; Lautscham, G; Humphries, E; Coulson, J; Blake, N (Cancer Immunol Immunother, 2007)